← Insider buys
KITE

Kite Pharma, Inc.

EVP, R, D, Chief Medical Offic David D Chang sold $4.7M of Kite Pharma, Inc.

Sold$4,749,441
$79.16Price
60,000Shares
−54%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Wed, Mar 1. Filed Thu, Mar 2, 1:08 AM ET, before the open. Not investment advice.